Effect of high doses intravenous IgG in newly diagnosed diabetic children

M. Pocecco, C. De Campo, L. Cantoni, F. Tedesco, F. Panizon

Research output: Contribution to journalArticle

Abstract

A controlled trial was carried out on type I diabetic children in order to evaluate the clinical effect of high doses intravenous gammaglobulins (i.v.IgG). Twenty newly diagnosed patients were admitted to the trial, ten of whom received 400 mg/kg body weight of i.v.IgG on 5 consecutive alternate days and subsequently after 15 days and monthly thereafter for up to six months, while ten patients served as controls. Insulin requirement in the treated and untreated groups was essentially similar at the start of the trial (0.94 ± 0.47 vs 1.11 ± 0.28) but showed a statistically significant difference at 3 (0.40 ± 0.28 vs 0.66 ± 0.26), 6 (0.36 ± 0.19 vs 0.63 ± 0.27) and 9 (0.38 ± 0.20 vs 0.62 ± 0.25) months. The difference was still evident at 12 months but no longer reached statistical significance. The reduced requirement of insulin was accompanied by a parallel increase in the C-peptide serum levels. Lymphocyte subpopulations, C3 and C4 and immune-complex levels did not show any significant modification after i.v. IgG administration.

Original languageEnglish
Pages (from-to)289-295
Number of pages7
JournalHelvetica Paediatrica Acta
Volume42
Issue number4
Publication statusPublished - 1987

Fingerprint

Immunoglobulin G
Insulin
C-Peptide
Lymphocyte Subsets
Antigen-Antibody Complex
Body Weight
Serum

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Pocecco, M., De Campo, C., Cantoni, L., Tedesco, F., & Panizon, F. (1987). Effect of high doses intravenous IgG in newly diagnosed diabetic children. Helvetica Paediatrica Acta, 42(4), 289-295.

Effect of high doses intravenous IgG in newly diagnosed diabetic children. / Pocecco, M.; De Campo, C.; Cantoni, L.; Tedesco, F.; Panizon, F.

In: Helvetica Paediatrica Acta, Vol. 42, No. 4, 1987, p. 289-295.

Research output: Contribution to journalArticle

Pocecco, M, De Campo, C, Cantoni, L, Tedesco, F & Panizon, F 1987, 'Effect of high doses intravenous IgG in newly diagnosed diabetic children', Helvetica Paediatrica Acta, vol. 42, no. 4, pp. 289-295.
Pocecco, M. ; De Campo, C. ; Cantoni, L. ; Tedesco, F. ; Panizon, F. / Effect of high doses intravenous IgG in newly diagnosed diabetic children. In: Helvetica Paediatrica Acta. 1987 ; Vol. 42, No. 4. pp. 289-295.
@article{7a61683ac7b743ae8b6e942db743e919,
title = "Effect of high doses intravenous IgG in newly diagnosed diabetic children",
abstract = "A controlled trial was carried out on type I diabetic children in order to evaluate the clinical effect of high doses intravenous gammaglobulins (i.v.IgG). Twenty newly diagnosed patients were admitted to the trial, ten of whom received 400 mg/kg body weight of i.v.IgG on 5 consecutive alternate days and subsequently after 15 days and monthly thereafter for up to six months, while ten patients served as controls. Insulin requirement in the treated and untreated groups was essentially similar at the start of the trial (0.94 ± 0.47 vs 1.11 ± 0.28) but showed a statistically significant difference at 3 (0.40 ± 0.28 vs 0.66 ± 0.26), 6 (0.36 ± 0.19 vs 0.63 ± 0.27) and 9 (0.38 ± 0.20 vs 0.62 ± 0.25) months. The difference was still evident at 12 months but no longer reached statistical significance. The reduced requirement of insulin was accompanied by a parallel increase in the C-peptide serum levels. Lymphocyte subpopulations, C3 and C4 and immune-complex levels did not show any significant modification after i.v. IgG administration.",
author = "M. Pocecco and {De Campo}, C. and L. Cantoni and F. Tedesco and F. Panizon",
year = "1987",
language = "English",
volume = "42",
pages = "289--295",
journal = "Helvetica Paediatrica Acta",
issn = "0018-022X",
publisher = "Schwabe und Co. AG",
number = "4",

}

TY - JOUR

T1 - Effect of high doses intravenous IgG in newly diagnosed diabetic children

AU - Pocecco, M.

AU - De Campo, C.

AU - Cantoni, L.

AU - Tedesco, F.

AU - Panizon, F.

PY - 1987

Y1 - 1987

N2 - A controlled trial was carried out on type I diabetic children in order to evaluate the clinical effect of high doses intravenous gammaglobulins (i.v.IgG). Twenty newly diagnosed patients were admitted to the trial, ten of whom received 400 mg/kg body weight of i.v.IgG on 5 consecutive alternate days and subsequently after 15 days and monthly thereafter for up to six months, while ten patients served as controls. Insulin requirement in the treated and untreated groups was essentially similar at the start of the trial (0.94 ± 0.47 vs 1.11 ± 0.28) but showed a statistically significant difference at 3 (0.40 ± 0.28 vs 0.66 ± 0.26), 6 (0.36 ± 0.19 vs 0.63 ± 0.27) and 9 (0.38 ± 0.20 vs 0.62 ± 0.25) months. The difference was still evident at 12 months but no longer reached statistical significance. The reduced requirement of insulin was accompanied by a parallel increase in the C-peptide serum levels. Lymphocyte subpopulations, C3 and C4 and immune-complex levels did not show any significant modification after i.v. IgG administration.

AB - A controlled trial was carried out on type I diabetic children in order to evaluate the clinical effect of high doses intravenous gammaglobulins (i.v.IgG). Twenty newly diagnosed patients were admitted to the trial, ten of whom received 400 mg/kg body weight of i.v.IgG on 5 consecutive alternate days and subsequently after 15 days and monthly thereafter for up to six months, while ten patients served as controls. Insulin requirement in the treated and untreated groups was essentially similar at the start of the trial (0.94 ± 0.47 vs 1.11 ± 0.28) but showed a statistically significant difference at 3 (0.40 ± 0.28 vs 0.66 ± 0.26), 6 (0.36 ± 0.19 vs 0.63 ± 0.27) and 9 (0.38 ± 0.20 vs 0.62 ± 0.25) months. The difference was still evident at 12 months but no longer reached statistical significance. The reduced requirement of insulin was accompanied by a parallel increase in the C-peptide serum levels. Lymphocyte subpopulations, C3 and C4 and immune-complex levels did not show any significant modification after i.v. IgG administration.

UR - http://www.scopus.com/inward/record.url?scp=0023605683&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023605683&partnerID=8YFLogxK

M3 - Article

C2 - 3327846

AN - SCOPUS:0023605683

VL - 42

SP - 289

EP - 295

JO - Helvetica Paediatrica Acta

JF - Helvetica Paediatrica Acta

SN - 0018-022X

IS - 4

ER -